<bill session="100" type="h" number="651" updated="2014-03-22T09:51:31-04:00">
  <state datetime="1987-01-21">REFERRED</state>
  <status>
    <introduced datetime="1987-01-21"/>
  </status>
  <introduced datetime="1987-01-21"/>
  <titles>
    <title type="official" as="introduced">A bill to provide that the effectiveness requirements of the Federal Food, Drug, and Cosmetic Act shall not apply to laetrile in certain cases.</title>
  </titles>
  <sponsor id="400586"/>
  <cosponsors/>
  <actions>
    <action datetime="1987-01-21" state="REFERRED">
      <text>Referred to House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="1987-01-29">
      <text>Referred to Subcommittee on Health and the Environment.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Drugs"/>
    <term name="Drug law and legislation"/>
    <term name="Drug safety and regulation"/>
    <term name="Drugs and narcotics"/>
    <term name="Health"/>
    <term name="Pain"/>
  </subjects>
  <amendments/>
  <summary>1/21/1987--Introduced.
Amends the Federal Food, Drug, and Cosmetic Act to exempt the use of laetrile for the treatment of pain under the direction of a physician from the effectiveness requirements of such Act.</summary>
</bill>
